Continuous Renal Replacement Therapy Market 2023| why Asia-Pacific held the largest market share

PUNE, India - Jan. 3, 2023 - PRLog -- Based on region, the market in Asia-Pacific held the largest market share of around one-third of the global continuous renal replacement therapy market in 2021, and is expected to maintain its lead position during the forecast period. The same segment is projected to manifest the fastest CAGR of 8.8% from 2022 to 2031. This is primarily attributed to the increase in number of initiatives along with rise in investments in R&D of CRRT products. In addition, increased focus of leading manufacturers on expanding their geographical presence and rise in healthcare expenditure drives the growth in the region.

According to the report published by Allied Market Research, The global Continuous Renal Replacement Therapy Market Size stood at USD 1.3 billion in 2021 and is projected to reach USD 2.6 billion by 2031, with a cagr of 7.7% during the period of 2022 to 2031.

Leading Market Players

• Fresenius Medical Care
• Baxter International
• Toray Industries Inc.
• SWS Hemodialysis Care
• Nipro Corporation
• Ningbo Tianyi Medical Devices
• NIKKISO Co. Ltd.
• Medtronic Plc.
• Medites Pharma spol. s.r.o
• Medical Components Inc.
• Medica S.p.A
• Infomed SA
• Cytosorbents
• Chongqing Shanwaishan Science and Technology
• B. Braun Melsungen Ag
• Asahi Kasei Corporation
• Anjue Medical Equipment Co. Ltd.

Request a Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/12288

Global Continuous Renal Replacement Therapy Market Segmentation: -

Based on product, the dialysates and replacement fluids segment was the largest market in 2021, contributing to nearly three-fifths of the global continuous renal replacement therapy market, and is expected to maintain its leadership status during the forecast period.

Based on modality,  the continuous venovenous hemofiltration (CVVH) segment held nearly one-third of the global continuous renal replacement therapy market share in 2021, and is expected to maintain its leadership status during the forecast period. CVVH is widely used to remove large volumes of fluid while avoiding the hypotensive episodes caused by intermittent hemodialysis.

Based on age group, the adults segment contributed to nearly two-thirds of the global continuous renal replacement therapy market in 2021 and is expected to maintain its dominance during the forecast period.

Get Full Report: https://www.alliedmarketresearch.com/continuous-renal-replacement-therapy-market-A11923